Journal of Hematology Oncology Pharmacy

🚨 September 22 is approaching fast. Have you registered? Join PMI's webinar to learn strategies for preventing common oncology claim denials before they reach your queue. Register now: bit.ly/4yaaMIp #OncologyPractice #RevenueCycle #MedicalBilling #PracticeManagement

September is Blood Cancer Awareness Month, a time to honor the strength of patients, survivors, caregivers, and families affected by blood cancers. #BloodCancer #Oncology #Hope #CancerResearch

New research puts numbers behind the essential role of ambulatory oncology pharmacists in patient education, treatment monitoring, and care coordination. Read more: bit.ly/4gW19oX #OncologyPharmacist #PharmacyLeadership #OncologyNews

Join the webinar "Stop Oncology Claim Denials Before They Start" and learn how leading oncology organizations are reducing denials, improving workflows, and strengthening revenue cycle performance. 📅 Sept. 22, 2026 🔗Learn more and register: bit.ly/3U0yMxQ

Despite advances in lung cancer care, many Black patients continue to encounter barriers that can affect diagnosis, treatment, and access to resources. What can healthcare teams do to help? Learn more: bit.ly/4xomZrY #LungCancer #HealthEquity #Oncology #CancerCare

Every denied claim tells a story. Are you listening? Learn how to turn denial data into actionable insights to uncover process gaps, improve reimbursement, and strengthen financial performance. 📅 9/22; 11-12:30 PM CST 🔗 Register: bit.ly/3U0yMxQ #RCM #PracticeManagement

📢 Daraxonrasib is now approved as treatment for adults with metastatic pancreatic adenocarcinoma 📢 Learn more: bit.ly/4qDpXX3 #PancreaticCancer #Oncology #CancerCare #PrecisionMedicine #ClinicalTrials

Cancer care doesn't stand still. Neither should you. Stay current on emerging therapies, evolving treatment strategies, and real-world clinical insights with In Practice™. Learn more and subscribe: bit.ly/4zC2idx #Oncology #Hematology #Pharmacey #CancerCare

Could a lower venetoclax dose be the smarter choice when used with azole antifungals? New evidence is challenging current practice and raising important questions about safety, efficacy, and cost. Read more: bit.ly/465andc #AML #CancerCare #Venetoclax #CancerResearch

Help patients access the care they need. Explore our FREE Patient Support Services Guide for financial assistance, copay support, and treatment access resources: bit.ly/4l9ekUz #CancerCare #Oncology #CopayAssistance #PatientAdvocacy #PracticeManagement

New insights from the KEYNOTE-522 trial are shedding light on dose-dense chemotherapy in triple-negative breast cancer. Learn what researchers found and how it could impact treatment decisions: bit.ly/3SFFA3E #TNBC #BreastCancer #Oncology #CancerTreatment #CancerResearch

Biosimilars continue to reshape cancer care. What impact can formulary conversion have on utilization, reimbursement, and costs in the real world? Explore the findings: bit.ly/4gcsJhg #Biosimilars #Oncology #CancerCare #PracticeManagement

Join the webinar "Stop Oncology Claim Denials Before They Start" and learn how leading oncology organizations are reducing denials, improving workflows, and strengthening revenue cycle performance. 📅 Sept. 22, 2026 🔗Learn more and register: bit.ly/3U0yMxQ

Can pharmacists help improve nausea and vomiting control in pediatric stem cell transplant patients? A new study highlights the impact of a guideline-driven antiemetic approach and the results may surprise you: bit.ly/4ggyMCv #Oncology #CancerTreatment #CancerResearch

Could proactive pharmacist monitoring make PARP inhibitor therapy safer and more effective? New research reveals how targeted follow-up during the first 90 days may help patients manage adverse events sooner: bit.ly/4fWgPJf #Oncology #CancerCare #CancerResearch

Multiple myeloma patients face an increased risk of blood clots, but are they getting the right anticoagulation therapy? New research explores anticoagulation practices in patients receiving IMiD therapy: bit.ly/47Mfpgq #MultipleMyeloma #Hematology #Oncology #CancerCare

An awareness check: Because sarcomas are rare, patients may have symptoms long before diagnosis. This Sarcoma and Bone Cancer Awareness Month, let's keep rare cancers on the differential when symptoms don't follow expectations. #BoneCancerAwareness #SarcomaAwareness #RareCancer

HER2-targeted therapy has transformed outcomes in breast cancer, but what happens when treatment starts affecting the heart? 💔 Explore the latest insights on trastuzumab-related cardiotoxicity: bit.ly/3RfQtsn #BreastCancer #HER2Positive #CardioOncology #CancerCare

☀️ UV Safety Awareness Month highlights the importance of taking time to remind patients that daily UV protection can help reduce cumulative UV exposure and lower skin cancer risk. #UVSafetyAwarenessMonth #CancerPrevention #PatientEducation #SunSafety

This article explores how decentralized clinical trials are evolving and why direct-to-patient shipment of investigational drugs may be key to expanding participation: bit.ly/4vqMzei #ClinicalTrials #Oncology #InvestigationalDrugs #ClinicalResearch #PatientAccess